Increased success of arteriovenous fistulas of the wrist. End Stage Renal Dieases
Conditions
Interventions
Intervention 1: Intervention group: The duration of treatment and follow-up for each patient will be a period of 6 weeks. From 2 weeks before the fistula implantation procedure and up to 2 weeks after
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: ESRD patients who have been diagnosed by a nephrologist as candidates for implantation of an arteriovenous fistula on the wrist (Cimino fistula). Patients whom Cimino fistula is performed for the first time. Patients who blood pressure range is more than 60/100 mm / Hg or less than 145/90 mm/Hg on the day of surgery. Patients older than 18 years
Exclusion criteria
Exclusion criteria: Blood pressure below 100/60 mm/Hg Absence of a suitable vessel (helical vein or arterial atherosclerosis) or artery diameter less than 2 and vein diameter less than 2.5 mm Patients who have used anticoagulants. Their vascular system is prepared for Cimino fistula VA and is not suitable for radio cephalic VA. Paralysis or ulceration of the organ where the fistula is to be implanted.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of premature failure of arteriovenous fistulas of the wrist. Timepoint: 6 weeks after surgery. Method of measurement: Observation and examination.;Accelerate the maturation of arteriovenous fistulas. Timepoint: 2 weeks before and 2 weeks after surgery. Method of measurement: Observation and examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Erythrocyte Sedimentation Rate. Timepoint: Before and after the intervention (weeks 0 and 6). Method of measurement: Blood Test.;Blood Urea Nitrogen (BUN ). Timepoint: Before and after the intervention (weeks 0 and 6). Method of measurement: Blood Test.;C Reactive Protein (CRP). Timepoint: Before and after the intervention (weeks 0 and 6). Method of measurement: Blood Test.;Creatinine (Cr). Timepoint: Before and after the intervention (weeks 0 and 6). Method of measurement: Blood Test.;White Blood Cell Count (WBC). Timepoint: Before and after the intervention (weeks 0 and 6). Method of measurement: Blood Test.;Blood Hemoglobin. Timepoint: Before and after the intervention (weeks 0 and 6). Method of measurement: Blood Test.;Red Blood Cell Distribution Width (RDW). Timepoint: Before and after the intervention (weeks 0 and 6). Method of measurement: Blood Test.;Prothrombin Time (PT). Timepoint: Before and after the intervention (weeks 0 and 6). Method of measurement: Blood Test.;Partial Thromboplastin Time (PTT). Timepoint: Before and after the intervention (weeks 0 and 6). Method of measurement: Blood Test.;International Normalized Ratio (INR). Timepoint: Before and after the intervention (weeks 0 and 6). Method of measurement: Blood Test.;Ferritin. Timepoint: Before and after the intervention (weeks 0 and 6). Method of measurement: Blood Test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohmmad Kamalinejad
Shahid Beheshti University of Medical Sciences
Outcome results
None listed